Conclusions: This study revealed that USP11/GREM1 could be a potential target for IPF management and identified that DMB could promote GREM1 degradation by inhibiting USP11, thereby alleviating pulmonary fibrosis. This evidence concerns the gene GREM1 and idiopathic pulmonary fibrosis.